Cole David K, Fuller Anna, Dolton Garry, Zervoudi Efthalia, Legut Mateusz, Miles Kim, Blanchfield Lori, Madura Florian, Holland Christopher J, Bulek Anna M, Bridgeman John S, Miles John J, Schauenburg Andrea J A, Beck Konrad, Evavold Brian D, Rizkallah Pierre J, Sewell Andrew K
Cardiff University School of Medicine, University Hospital, Heath Park, Cardiff, United Kingdom.
Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States.
Front Immunol. 2017 Nov 10;8:1503. doi: 10.3389/fimmu.2017.01503. eCollection 2017.
Serial accumulation of mutations to fixation in the SLYNTVATL (SL9) immunodominant, HIV p17 Gag-derived, HLA A2-restricted cytotoxic T lymphocyte epitope produce the SLFNTIAVL triple mutant "ultimate" escape variant. These mutations in solvent-exposed residues are believed to interfere with TCR recognition, although confirmation has awaited structural verification. Here, we solved a TCR co-complex structure with SL9 and the triple escape mutant to determine the mechanism of immune escape in this eminent system. We show that, in contrast to prevailing hypotheses, the main TCR contact residue is 4N and the dominant mechanism of escape is not lack of TCR engagement. Instead, mutation of solvent-exposed residues in the peptide destabilise the peptide-HLA and reduce peptide density at the cell surface. These results highlight the extraordinary lengths that HIV employs to evade detection by high-affinity TCRs with a broad peptide-binding footprint and necessitate re-evaluation of this exemplar model of HIV TCR escape.
在SLYNTVATL(SL9)免疫显性、HIV p17 Gag衍生、HLA A2限制性细胞毒性T淋巴细胞表位中,突变不断积累直至固定,产生了SLFNTIAVL三重突变“终极”逃逸变体。尽管尚未得到结构验证,但据信这些溶剂暴露残基中的突变会干扰TCR识别。在此,我们解析了SL9与三重逃逸突变体的TCR共复合物结构,以确定这一著名系统中的免疫逃逸机制。我们发现,与普遍假设相反,主要的TCR接触残基是4N,逃逸的主要机制并非TCR无法结合。相反,肽中溶剂暴露残基的突变会使肽-HLA不稳定,并降低细胞表面的肽密度。这些结果凸显了HIV为逃避具有广泛肽结合足迹的高亲和力TCR检测所采取的非凡手段,也有必要重新评估这一HIV TCR逃逸的典型模型。